Serum thrombospondin-2 level changes with liver stiffness improvement in patients with type 2 diabetes.

Autor: Mak JHC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lui DT; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Fong CH; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Cheung CY; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Wong Y; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lee AC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Hoo RL; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Xu A; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Tan KC; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lam KS; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lee CH; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Publikováno v: Clinical endocrinology [Clin Endocrinol (Oxf)] 2024 Mar; Vol. 100 (3), pp. 230-237. Date of Electronic Publication: 2023 Dec 21.

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation.

Autor: Lin H; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Wang L; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.; The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Liu Z; The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, 518000, P. R. China., Long K; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Kong M; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Ye D; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, 510000, P. R. China., Chen X; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Wang K; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Wu KK; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong., Fan M; Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, 510000, P. R. China., Song E; Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510000, P. R. China., Wang C; Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510000, P. R. China., Hoo RL; The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Pharmacology and Pharmacy, The University of Hong Kong, Pokfulam, Hong Kong., Hui X; The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Hallenborg P; Department of Biochemistry and Molecular Biology, University of Southern Denmark, Southern Denmark, 5230, Denmark., Piao H; Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116000, P. R. China., Xu A; The State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.; Department of Pharmacology and Pharmacy, The University of Hong Kong, Pokfulam, Hong Kong., Cheng KK; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2022 Jul; Vol. 9 (20), pp. e2200742. Date of Electronic Publication: 2022 May 07.

Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages.

Autor: Xiao Y; National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China., Shu L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Hematologic Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, China.; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Medicine, and., Wu X; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Pharmacology & Pharmacy, The University of Hong Kong, Hong Kong, China., Liu Y; Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Cheong LY; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Medicine, and., Liao B; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Pharmacology & Pharmacy, The University of Hong Kong, Hong Kong, China., Xiao X; National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China., Hoo RL; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Pharmacology & Pharmacy, The University of Hong Kong, Hong Kong, China., Zhou Z; National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China., Xu A; State Key Laboratory of Pharmaceutical Biotechnology.; Department of Medicine, and.; Department of Pharmacology & Pharmacy, The University of Hong Kong, Hong Kong, China.

Publikováno v: JCI insight [JCI Insight] 2021 Apr 08; Vol. 6 (7). Date of Electronic Publication: 2021 Apr 08.

Plasma and breast milk adipokines in women across the first year postpartum and their association with maternal depressive symptoms and infant neurodevelopment: Protocol for the APPLE prospective cohort study.

Autor: Rebelo, Fernanda¹ (AUTHOR) frebelos@gmail.com, de Moura, Cintia Oliveira² (AUTHOR), Ranquine, Layla Galvão³ (AUTHOR), Teixeira, Thaisa de Mattos⁴ (AUTHOR), Ribas, Mariana Terra Nunes³ (AUTHOR), Vitorino, Raquel Santiago⁴ (AUTHOR), de Abranches, Andrea Dunshee¹ (AUTHOR), Costa, Roozemeria Pereira¹ (AUTHOR), de Britto, José Augusto Alves⁵ (AUTHOR), Marano, Daniele¹ (AUTHOR), Soares, Fernanda Valente Mendes¹ (AUTHOR), Junqueira-Marinho, Maria de Fátima¹ (AUTHOR), de Sousa, Carlos Augusto Moreira⁶ (AUTHOR), Franco-Sena, Ana Beatriz⁷ (AUTHOR), Nardi, Antônio Egídio⁸ (AUTHOR), El-Bacha, Tatiana³ (AUTHOR), Moreira, Maria Elisabeth Lopes¹ (AUTHOR)

Publikováno v: PLoS ONE. 10/25/2024, Vol. 19 Issue 10, p1-15. 15p.

Amauroderma rugosum Protects PC12 Cells against 6-OHDA-Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects.

Autor: Li J; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China., Li R; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China., Wu X; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China., Hoo RL; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China., Lee SM; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, China., Cheung TM; Tian Ran Healthcare Limited, Hong Kong, China., Ho BS; Tian Ran Healthcare Limited, Hong Kong, China., Leung GP; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.

Publikováno v: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2021 Feb 03; Vol. 2021, pp. 6683270. Date of Electronic Publication: 2021 Feb 03 (Print Publication: 2021).